Vitamin Biomarkers Market Report 2025

This Vitamin Biomarkers market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The vitamin biomarkers market size has grown rapidly in recent years. It will grow from $3.59 billion in 2024 to $4.06 billion in 2025 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to growing awareness of vitamin deficiencies, increasing prevalence of chronic diseases, rising demand for personalized nutrition, increasing research on nutritional biomarkers, and growing geriatric population.

The vitamin biomarkers market size is expected to see rapid growth in the next few years. It will grow to $6.56 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to growing adoption of digital health solutions, increasing focus on early disease detection, rising demand for home-based testing kits, increasing healthcare expenditure, and rising consumer interest in health and wellness. Major trends in the forecast period include integration of wearable health technology, development of multi-biomarker panels, advancements in high-throughput screening methods, development of novel biomarker-based tests, and enhanced digital and remote health monitoring.

The rising prevalence of nutrition deficiencies is anticipated to drive growth in the vitamin biomarkers market. Nutrition deficiencies, which result from a lack of essential nutrients in the diet and can lead to adverse health effects, are influenced by poor dietary habits, limited access to diverse foods, and socio-economic factors. Vitamin biomarkers help diagnose these deficiencies by measuring specific vitamins in the blood to assess nutritional status and guide appropriate interventions. For example, a July 2023 report by the Food and Agriculture Organization, an Italy-based non-profit organization, noted that the prevalence of undernourishment defined as the percentage of a population whose dietary energy intake is insufficient to meet minimum energy requirements for a healthy and active life affected about 9.2% of the global population in 2022, up from 7.9% in 2021. In Africa, this prevalence increased by 0.3 percentage points, rising from 19.4% in 2021 to 19.7% in 2022. Consequently, the growing prevalence of nutrition deficiencies is expected to fuel the expansion of the vitamin biomarkers market.

The growing emphasis on personalized medicine is anticipated to drive the expansion of the vitamin biomarkers market in the coming years. Personalized medicine is a healthcare approach that customizes treatment and care strategies based on the unique characteristics, genetics, and needs of each patient. This shift is largely due to advancements in genomics, biotechnology, and data analytics, which allow for treatments to be tailored according to individual genetic profiles and personal health information. Vitamin biomarkers play a crucial role in personalized medicine by offering insights into an individual's nutritional status and metabolic functions, thereby facilitating customized treatment plans to enhance health outcomes. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based non-profit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, an increase from six in 2022. The newly approved treatments for 2023 included seven cancer drugs and three for other diseases and conditions. Consequently, the heightened focus on personalized medicine is propelling the growth of the vitamin biomarkers market.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical equipment manufacturer, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed amount. This acquisition is expected to strengthen Mindray's position in the diagnostic solutions market and broaden its technological capabilities. DiaSys Diagnostic Systems GmbH, based in Germany, specializes in researching and developing a range of biomarkers, including those related to vitamins.

Major companies operating in the vitamin biomarkers market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Roche Diagnostics International Ltd., Agilent Technologies Inc, PerkinElmer Inc, bioMérieux SA, Beckman Coulter Inc, Shimadzu Corporation, QuidelOrtho Corporation, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc, Tecan Group Ltd, Randox Laboratories Ltd, Ortho Clinical Diagnostics Inc, Molecular Devices LLC, Cambridge Isotope Laboratories Inc, Luminex Corporation, DiaSorin SpA, Analytik Jena AG, SeraCare Life Sciences Inc, Biopanda Reagents Ltd, SiPhox Inc.

North America was the largest region in the vitamin biomarkers market in 2024. The regions covered in the vitamin biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the vitamin biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Vitamin biomarkers are measurable indicators in the body that reflect the levels or status of specific vitamins. They are used to assess an individual’s nutritional state and diagnose deficiencies or excesses of certain vitamins. These biomarkers are typically measured through blood, urine, or tissue samples and provide insights into how effectively the body absorbs, metabolizes, and utilizes vitamins.

The main types of vitamin biomarkers include serum retinol (vitamin A), ascorbic acid (vitamin C), serum 25(OH)D (vitamin D), serum alpha-tocopherol (vitamin E), serum prothrombin (vitamin K), serum thiamine diphosphate (vitamin B1), serum riboflavin (vitamin B2), serum niacin (vitamin B3), and serum plasma PLP (vitamin B6), among others. For example, serum retinol, which measures the concentration of vitamin A in the blood, is crucial for vision, immune function, and skin health and helps in diagnosing vitamin A deficiencies or excesses. Products for measuring these biomarkers include analyzers, test kits, reagents, and consumables, using testing methods such as enzyme-linked immunosorbent assays (ELISA), liquid chromatography with tandem mass spectrometry (LC-MS/MS), high-performance liquid chromatography (HPLC), and chemiluminescent immunoassays (CLIA). These products are used by various end users, including hospitals, diagnostic laboratories, ambulatory diagnostic centers, and homecare settings.

The vitamin biomarkers market research report is one of a series of new reports that provides vitamin biomarkers market statistics, including vitamin biomarkers industry global market size, regional shares, competitors with an vitamin biomarkers market share, detailed vitamin biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the vitamin biomarkers industry. This vitamin biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vitamin biomarkers market consists of revenues earned by entities by providing services such as vitamin level testing, diagnostic assessments, nutritional monitoring, and personalized health management to detect deficiencies or excesses of specific vitamins. The market value includes the value of related goods sold by the service provider or included within the service offering. The vitamin biomarkers market also includes sales of diagnostic assays, test kits, laboratory reagents, analytical instruments, and point-of-care devices used to measure and analyze vitamin levels in biological samples. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.